30 June 2011
Calcineurin inhibitor-based and free regimens have distinct gene expression patterns in subclinical graft fibrosis
Huseyin TozACDEF, Sait SenBD, Handan Ak CelikBCD, Mumtaz YilmazACDEF, Ender HurBC, Cuneyt HoscoskunABC, Mehmet OzkahyaBC, Hikmet Hakan AydinACDEAnn Transplant 2011; 16(2): 76-87 :: ID: 881869
Abstract
Background: Chronic nephrotoxic effects of calcineurin inhibitors may be responsible for late allograft dysfunction and reduced allograft half-life. Mammalian target of rapamycin inhibitors (mTOR-i’s), a newer class of immunosuppressant, do not have the chronic nephrotoxic effects shown with calcineurin inhibitors (CNI). Whether these drug classes have distinct features at the molecular level is not clear.
Material/Methods: Difference in gene expression profiles of kidney graft protocol biopsies from patients treated with CNI or mTOR-i’s were investigated. Biopsies from patients using CNI (n=4) and mTOR-i-based treatments (n=4) were analyzed. The control group consisted of 5 biopsies obtained at the time of implantation (zero hour). Microarray hybridization was performed using the Affymetrix® GeneChip U133 plus 2.0 Array.
Results: In the CNI and mTOR-i groups, 64 up-regulated and 119 down-regulated genes were found compared to control subjects. A total of 29 genes in the CNI group and 101 genes in the mTOR-i group were up-regulated compared to each other.
Conclusions: Despite similar clinical courses and histopathological appearances, different treatment strategies cause different gene expression profiles in kidney transplantation.
Keywords: Kidney Transplantation, mTOR, microarray analysis.
Most Viewed Current Articles
24 Aug 2021 : Review article 22,636
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Sep 2015 : Review article 19,107
Risk Factors for Chronic Renal Insufficiency Following Cardiac TransplantationDOI :10.12659/AOT.893788
Ann Transplant 2015; 20:576-587
29 Dec 2021 : Original article 18,791
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
11 Aug 2015 : Original article 17,619
Twelve-Hour Hypothermic Machine Perfusion for Donor Heart Preservation Leads to Improved Ultrastructural Ch...DOI :10.12659/AOT.893784
Ann Transplant 2015; 20:461-468






